19 May 2013
Keywords: UK, NICE, Pricing decisions, Value-based medicines, ABPI
Article | 02 November 2010
The UK drug watchdog body, the National Institute for Health and Clinical Excellence (NICE), will no longer be able to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 November 2010
1 November 2010
17 May 2013
© 2013 thepharmaletter.com